[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
April 18, 2007

Diabetes Drugs Tied to Fractures in Women

JAMA. 2007;297(15):1645. doi:10.1001/jama.297.15.1645

A warning from the US Food and Drug Administration (FDA) has linked pioglitazone (Actos), a thiazolidinedione prescribed for the treatment of type 2 diabetes, with an increased rate of arm, hand, and lower leg fractures among women. The action comes less than a month after a similar warning about excess fractures in women taking rosiglitazone (Avandia), another drug in the same class. The increased risk did not appear in men.

While the drugs remain on the market and continue to be valuable tools in physicians' therapeutic armamentarium against type 2 diabetes, investigators are striving to determine the mechanism of these effects and which patients are at increased risk.

First Page Preview View Large
First page PDF preview
First page PDF preview
×